Accéder au contenu
Merck

Antiaggressive effects of topiramate in agonistic encounters between male mice.

Methods and findings in experimental and clinical pharmacology (2007-05-24)
Jose Francisco Navarro, E Buron, M Martin-Lopez
RÉSUMÉ

Topiramate, an antiepileptic drug, has been found to be useful for the treatment of aggression in clinical populations. However, no studies have explored the action of this compound on aggressive behavior in laboratory animals. This work examined the effects of topiramate (10, 20, 40 and 80 mg/kg, i.p.) on agonistic interactions between male mice, using an ethopharmacological approach. Individually housed mice were exposed to anosmic "standard opponents" 30 min after drug administration. Ten minutes of diadic interactions were staged between a singly housed and an anosmic mouse in a neutral area. The encounters were videotaped and the accumulated time allocated by subjects to 10 broad behavioral categories was estimated using an ethologically based analysis. Results showed that topiramate (20-80 mg/kg) produced a significant reduction of offensive behaviors (threat and attack), without affecting immobility. Digging behavior (all doses) was also significantly decreased. The antiaggressive effects of topiramate could be related to its ability for modulating positively GABA-A receptors and/or blocking AMPA subtype of glutamate receptors.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Topiramate, ≥98% (HPLC), solid